Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing anticholinergic side effects.

Joseph A Lieberman1

  • 1Jefferson Medical College, Philadelphia, Pennsylvania, USA. jlieberman@jalmd.com

Primary Care Companion to the Journal of Clinical Psychiatry
|July 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excessive sleepiness and self-reported shift work disorder: an Internet survey of shift workers.

Postgraduate medicine·2013
Same author

2011 recommendations for the diagnosis and management of gout and hyperuricemia.

The Physician and sportsmedicine·2012
Same author

2011 Recommendations for the diagnosis and management of gout and hyperuricemia.

Postgraduate medicine·2011
Same author

Treatment and prophylaxis of gout flare in the clinic: an office-based approach to gout management.

Postgraduate medicine·2011
Same author

Identifying depression in primary care.

Postgraduate medicine·2009
Same author

Insomnia in primary care: overcoming diagnostic and treatment barriers. Introduction.

Postgraduate medicine·2009
Same journal

Clinical relevance of disturbances of sleep and vigilance in major depressive disorder: a review.

Primary care companion to the Journal of clinical psychiatry·2011
Same journal

Psychiatric treatment needs among the medically underserved: a study of black and white primary care patients residing in a racial minority neighborhood.

Primary care companion to the Journal of clinical psychiatry·2011
Same journal

The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional study.

Primary care companion to the Journal of clinical psychiatry·2011
Same journal

Gambling and completed suicide in Hong Kong: a review of coroner court files.

Primary care companion to the Journal of clinical psychiatry·2011
Same journal

Adverse reactions to zolpidem: case reports and a review of the literature.

Primary care companion to the Journal of clinical psychiatry·2011
Same journal

Psychiatric care of the patient with hepatitis C: a review of the literature.

Primary care companion to the Journal of clinical psychiatry·2011
See all related articles

Atypical antipsychotics have fewer movement side effects but can cause harmful anticholinergic side effects. Recognizing and managing these anticholinergic effects is crucial for patient care.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Medicine

Background:

  • Atypical antipsychotics offer advantages over conventional antipsychotics regarding extrapyramidal symptoms (EPS) and tardive dyskinesia.
  • However, atypical antipsychotics are associated with a distinct set of adverse effects, notably anticholinergic side effects.
  • These anticholinergic effects, both peripheral and central, can lead to significant physical and cognitive impairment in patients.

Purpose of the Study:

  • To highlight the potential for anticholinergic side effects associated with atypical antipsychotic medications.
  • To emphasize the importance of recognizing and managing these specific adverse effects.
  • To provide guidance for physicians in treating patients requiring antipsychotic therapy while minimizing anticholinergic burden.

Main Methods:

Related Experiment Videos

  • Review of existing literature on atypical antipsychotics and their side effect profiles.
  • Analysis of the mechanisms and clinical manifestations of anticholinergic side effects.
  • Discussion of management strategies for anticholinergic toxicity in patients on antipsychotics.

Main Results:

  • Atypical antipsychotics, while reducing EPS risk, frequently cause anticholinergic side effects.
  • Peripheral anticholinergic effects include dry mouth, blurred vision, constipation, and urinary retention.
  • Central anticholinergic effects can manifest as cognitive impairment, confusion, and sedation.

Conclusions:

  • Physicians must be aware of the anticholinergic potential of atypical antipsychotics.
  • Early identification and management of anticholinergic side effects are essential for patient safety and treatment adherence.
  • A balanced approach is needed to weigh the benefits of antipsychotic therapy against the risks of anticholinergic adverse events.